Lenolidomide capsules

Ended Awarded Last action

Contract number
36C26326F0016
Awardee
Awarding agency
Obligated
$3,600,000

Award facts

Contract value 100% obligated
$3,600,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Iowa City, IA 52246, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network 23 awarded a $3.6M firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. The contract was awarded on December 1, 2025, with an ultimate completion date of September 30, 2026, and carries no set-aside designation. Performance will take place in Iowa City, Iowa. This delivery order falls under the GSA Schedule Pharmaceuticals and Drugs contract vehicle (FSS-61-IB), enabling the VA to procure pharmaceutical products through a pre-competed schedule arrangement.

Exelan Pharmaceuticals, a foreign-owned pharmaceutical company headquartered in Boca Raton, Florida, specializes in manufacturing, distributing, and repackaging generic and branded pharmaceutical products for federal healthcare systems. The company maintains an established track record supplying the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through competitive procurements and multiple indefinite delivery contracts with values spanning tens of thousands to millions of dollars. Lenalidomide, a critical immunomodulatory agent used in cancer treatment, represents a significant therapeutic pharmaceutical within Exelan's portfolio of federal pharmaceutical supply contracts, supporting the VA's mission to provide comprehensive healthcare services to eligible veterans.

Quick answers

Who was awarded contract 36C26326F0016?

36C26326F0016 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on December 1, 2025.

How much is contract 36C26326F0016 worth?

The government has obligated $3,600,000 on 36C26326F0016.

Is contract 36C26326F0016 an order under another contract?

Yes. 36C26326F0016 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26326F0016 competed?

The extent of competition for 36C26326F0016 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award